OncoImmune competitors and similar companiesClear all

OncoImmune's competitors and similar companies include Acerta Pharma, Deciphera Pharmaceuticals, Puma Biotechnology and CureVac.
OncoImmune
OncoImmune
OncoImmune is a company engaged in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease.
Acerta Pharma
Acerta Pharma
Acerta Pharma is a biopharmaceutical company.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
CureVac
CureVac
CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.
Founding Date
Founding Date
2000
Founding Date
2013
Founding Date
2003
Founding Date
2010
Founding Date
2000
Type
Type
Subsidiary
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Rockville, US HQ
Locations
South San Francisco, US HQ
Oss, NL
Oss, NL
Locations
Waltham, US HQ
Lawrence, US
Locations
Los Angeles, US HQ
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Employees
Employees
9
Employees
197
Employees
35037% increase
Employees
27214% decrease
Employees
4004% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
1.1 b
Valuation ($)
96.1 m
Valuation ($)
1.5 b
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
723
Twitter followers
N/A
Twitter followers
8
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
762137
Alexa Website Rank
750751
Alexa Website Rank
413496
Alexa Website Rank
321184
Employee Rating
Employee Rating
N/A
Employee Rating
3.5
Employee Rating
3.7
Employee Rating
3.2
Employee Rating
3.2

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$253.2m (FY, 2021)
Revenue (est.)
€12.6m (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$63.7m (FY, 2021)
Cost of goods
€22.3m (FY, 2018)
Net income
Net income
N/A
Net income
N/A
Net income
($25.9m) (FY, 2016)
Net income
($29.1m) (FY, 2021)
Net income
(€74.6m) (FY, 2018)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
49 (Aug, 2017)
Patent Applications
N/A
Patent Applications
500 (Mar, 2020)

Funding

Total funding raised
Total funding raised
$ 71.8m
Total funding raised
$ 60m
Total funding raised
$ 714m
Total funding raised
$ 172m
Total funding raised
$ 1.1b
For sources of this data, please see the company profile

View company profiles

Acerta Pharma
HQ
South San Francisco, US

Acerta Pharma is a biopharmaceutical company.

View company
Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.

View company
Puma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

View company
CureVac
HQ
Tübingen, DE
Employees
400↑ 4% increase

CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.

View company